Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine.
Philipp ProbstMarco StringhiniDanilo RitzTim FugmannDario NeriPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)
Because both peptide vaccination strategies and tumor-homing TNF fusion proteins are currently being studied in clinical trials, our study provides a rationale for the combination of these 2 regimens for the treatment of patients with cancer.